Seeing Is Believing
Healthcare - Sector
KRYS is currently covered by 9 analysts with an average price target of $335.67. This is a potential upside of $45.31 (7.39%) from yesterday's end of day stock price of $312.57.
Krystal Biotech's activity chart (see below) currently has 139 price targets and 129 ratings on display. The stock rating distribution of KRYS is 89.66% BUY and 10.34% HOLD.
Analysts average stock forecasts to be materialized ratio is 98.53% with an average time for these price targets to be met of 223 days.
Highest price target for KRYS is $403, Lowest price target is $217, average price target is $335.67.
Most recent stock forecast was given by ALEC STRANAHAN from BAML on 14-Jul-2026. First documented stock forecast 18-Oct-2017.
Currently out of the existing stock ratings of KRYS, 26 are a BUY (89.66%), 3 are a HOLD (10.34%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 19-Jan-2022
$396
$54.88 (16.09%)
$318
20 days ago
(14-Jul-2026)
8/9 (88.89%)
$56.57 (16.67%)
183
Buy Since 29-Nov-2021
$403
$61.88 (18.14%)
$306
1 months 16 days ago
(18-Jun-2026)
9/10 (90%)
$54.94 (15.78%)
254
Buy Since 24-Sep-2018
$361
$19.88 (5.83%)
$310
1 months 18 days ago
(16-Jun-2026)
46/46 (100%)
$37.63 (11.64%)
207
Buy Since 12-Jan-2026
$378
$36.88 (10.81%)
$371
2 months 29 days ago
(05-May-2026)
10/10 (100%)
$93.43 (32.83%)
178
Buy Since 29-Mar-2022
$284
$-57.12 (-16.74%)
$189
5 months 9 days ago
(25-Feb-2026)
6/6 (100%)
$11.5 (4.22%)
128
What is KRYS (Krystal Biotech) average time for price targets to be met?
Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?
Which analyst has the most public recommendations on KRYS (Krystal Biotech)?
Which analyst is the currently most bullish on KRYS (Krystal Biotech)?
Which analyst is the currently most reserved on KRYS (Krystal Biotech)?